t1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR QUALITATIVE Test
Test Name: t1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR QUALITATIVE Test
Components: Price: 1000.0 AED
Sample Condition: 3mL(2mLmin.) wholeblood/Bone marrowin1LavenderTop(EDTA) tube. Ship refrigerated. DO NOT FREEZE. Clinical history is mandatory.
Report Delivery: Sample by Mon/Thu by 11am; Report on Wed/Sat
Method: Real Time PCR
Test type: Leukemia
Doctor: Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Clinical history is mandatory.
Test Details
The t(12;21) (p13;q22) ETV6-RUNX1 (TEL-AML1) PCR qualitative test is a diagnostic test used to detect the presence of a specific genetic abnormality known as the ETV6-RUNX1 fusion gene. This fusion gene is commonly found in pediatric patients with acute lymphoblastic leukemia (ALL).
The test involves extracting genetic material (DNA) from the patient’s blood or bone marrow sample. The DNA is then amplified using a technique called polymerase chain reaction (PCR), which specifically targets the ETV6-RUNX1 fusion gene.
If the fusion gene is present in the patient’s sample, the PCR amplification will produce a positive result, indicating the presence of the genetic abnormality.
This test is qualitative, meaning it determines the presence or absence of the ETV6-RUNX1 fusion gene, but does not provide information about the quantity or level of the fusion gene.
It is commonly used as part of the diagnostic workup for pediatric ALL patients to confirm the presence of the ETV6-RUNX1 fusion gene, which can help guide treatment decisions.
Test Name | t1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR QUALITATIVE Test |
---|---|
Components | |
Price | 1000.0 AED |
Sample Condition | 3mL(2mLmin.) wholeblood\/Bone marrowin1LavenderTop(EDTA) tube.Shiprefrigerated.DONOT FREEZE. Clinical history is mandatory. |
Report Delivery | SamplebyMon / Thuby 11am;Report Wed / Sat |
Method | Real Time PCR |
Test type | Leukemia |
Doctor | Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Clinical history is mandatory. |
Test Details | The t(12;21) (p13;q22) ETV6-RUNX1 (TEL-AML1) PCR qualitative test is a diagnostic test used to detect the presence of a specific genetic abnormality known as the ETV6-RUNX1 fusion gene. This fusion gene is commonly found in pediatric patients with acute lymphoblastic leukemia (ALL). The test involves extracting genetic material (DNA) from the patient’s blood or bone marrow sample. The DNA is then amplified using a technique called polymerase chain reaction (PCR), which specifically targets the ETV6-RUNX1 fusion gene. If the fusion gene is present in the patient’s sample, the PCR amplification will produce a positive result, indicating the presence of the genetic abnormality. This test is qualitative, meaning it determines the presence or absence of the ETV6-RUNX1 fusion gene, but does not provide information about the quantity or level of the fusion gene. It is commonly used as part of the diagnostic workup for pediatric ALL patients to confirm the presence of the ETV6-RUNX1 fusion gene, which can help guide treatment decisions. |